Clicky

Medibio Limited(MEB)

Description: Medibio Limited, a health technology company, researches, develops, and commercializes mental health technology to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions in Australia and the United States. It offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. Medibio Limited has a clinical trial agreement with MedBridge Healthcare LLC to support Medibio's sleep analysis of depressive burden (SADB) trial. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is based in Melbourne, Australia.


Keywords: Health Care Mental Health Psychiatric Diagnosis Depression Psychiatry Primary Care Major Depressive Disorder Health Technology Mental Disorder Abnormal Psychology Management Of Depression Healthcare Provider Market Mental Health Technology

Home Page: medibio.com.au

MEB Technical Analysis

100 Albert Road
Melbourne, VIC 3205
Australia
Phone: 61 3 9692 7222


Officers

Name Title
Dr. Thomas R. Young M.D. Chief Exec. Officer
Ms. Renee Stanton-Horne Operations & Account Mang.
Ms. Stephanie Ottens Investor Relations Director
Mr. Josh Purdy PR Director
Dr. Michael Player Head of Research
Dr. Matthew Flax Head of Algorithm Devel. Team
Mr. Archie Defillo M.D. Chief Medical Officer
Ms. Jennifer Solitario Sr. VP of Corp. Health
Mr. Massimiliano Grassi Head of Artificial Intelligence
Mr. Mathew Watkins C.A. Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.4673
Price-to-Sales TTM: 6.6052
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks